Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × NIH × Clear all

Phase

Phase 2 46 Phase 1 21 Phase 1/2 15 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Completed 89 Unknown 51 Recruiting 13 Terminated 10 Active not recruiting 6 Enrolling by invitation 2 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

OTHER 636 INDUSTRY 36 OTHER_GOV 8 NETWORK 6 FED 3 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hodgkin Disease 1

Interventions

fludarabine phosphate 1 Cyclophosphamide 1 B3(Fv)-PE38KDEL recombinant immunotoxin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00389506 2012-03-16

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase NA Withdrawn

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡